Kindbody Names David Stern as Chief Executive Officer to Lead Next Stage of Growth

Jun 10

Written By Matthew Blind

Matthew Blind

Skyhawk Therapeutics Announces First Patient Dosed in Phase 2/3 FALCON-HD Trial of SKY-0515 for Huntington's Disease

Loadsmart Named in the 2025 Gartner® Midmarket Context: ‘Magic Quadrant™ for Transportation Management Systems’